Sponsor:
Canadian Immunization Research Network
Code:
NCT07097012
Conditions
RSV
Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination
Pregnancy
Healthy
Eligibility Criteria
Sex: Female
Age: 18 - 49
Healthy Volunteers: Not accepted
Interventions
Tdap Vaccine Administration
RSV Vaccine
Saline (as a placebo)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-18. This information was provided to ClinicalTrials.gov by Canadian Immunization Research Network on 2025-11-17.